In this issue of Blood, Yang et al have proposed that for early-stage nasal type natural killer (NK)/T-cell lymphoma, combined radiotherapy (RT), and chemotherapy (CT) improve survival, but CT can be safely omitted in certain low-risk patients treated with RT.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1182/blood-2015-07-655191 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!